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Introduction
Total thyroidectomy is a common surgical procedure and is 
often the treatment of choice for a number of benign and 
malignant conditions. However, despite being a relatively 
safe procedure in experienced hands, hypoparathyroidism 
remains one of the most common complications (1,2). 
Patients suffering from postoperative hypoparathyroidism 
generally present with a low postoperative serum 
calcium (Ca), a high phosphate and a low parathyroid 
hormone (PTH) level. Symptomatic hypocalcemia (such 
as numbness, muscle spasms, confusion) may occur, 
although it is getting less common because of the improved 
postoperative Ca management (3). Regarding the etiology 
of postoperative hypoparathyroidism, it is generally thought 
that it is due to a transient reduction in blood supply of 
in situ parathyroid glands (PGs), which results in a transient 
reduction of parathyroid function (or hormone secretion). 
Although inadvertent removal of PGs (i.e., incidental 
parathyroidectomy) may contribute to hypoparathyroidism, 
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it does not happen often. As a result, provided the PG is 
not entirely stripped of its blood supply, normalization of 
parathyroid function is expected for the majority of patients. 
Nevertheless, this recovery phase may take several weeks 
to months (i.e., protracted hypoparathyroidism) (2). After 
normalization, patients are usually able to stop their oral 
Ca ± calcitriol supplements. However, a small proportion 
(<5%) may not have their parathyroid function normalized 
and they are considered as having persistent or permanent 
hypoparathyroidism. The reported rates of temporary 
and permanent hypoparathyroidism in the literature vary 
widely between 19% to 38% and 0% to 3% respectively, 
depending on the definition of hypoparathyroidism (4), 
casemix and type of thyroid resections.
Although postoperative hypoparathyroidism can 
often be managed by taking regular oral Ca ± vitamin D 
supplements, some patients may experience persistent 
hypocalcemic symptoms leading to impaired daily living 
and quality of life. This situation also poses challenges 
to clinicians and increases health costs (5-7). Long term 
morbidities such as renal failure, basal ganglia calcifications, 
neuropsychiatric derangements and infections have been 
reported as a result of supplementation over a prolonged 
period (8,9).
Risk factors leading to postoperative 
hypoparathyroidism
The extent of resection and surgical technique are 
factors known to influence the subsequent risk of 
postoperative hypoparathyroidism (10). For instance, 
patients who undergo a bilateral thyroidectomy are 
at greater risk of hypoparathyroidism than those who 
undergo a unilateral thyroidectomy (10,11). Similarly, 
those who undergo peripheral ligation of the inferior 
thyroid artery at the thyroid capsule are more prone to 
develop hypoparathyroidism than those who undergo sub-
capsular dissection (10). Parathyroid auto-transplantation, 
inadvertent excision of PGs and presence of PGs in the 
thyroid specimen have also been shown to increase the 
risk of post-operative hypoparathyroidism (1,11-17). This 
is because they all lower the number of in situ PGs and 
therefore, the residual parathyroid function is immediately 
compromised. Concomitant central neck dissection has also 
been found to be an independent risk factor, presumably 
because this procedure increases risk of incidental 
parathyroidectomy (15,16). Surgeon’s experience (12) and 
hospital operative volume (11) have also been shown to 
be important in post-operative hypoparathyroidism. After 
operation, clinical symptoms and signs such as numbness 
and tetany, as well as serum Ca level should be monitored. 
Some suggested that an early postoperative decrease in 
serum iPTH concentrations (8,10), combining with serum 
Ca concentration may predict hypoparathyroidism and 
guide the administration of Ca or vitamin D supplements 
(18,19). Post-operative hypoparathyroidism results from a 
reduction of functioning parathyroid parenchyma, which 
could be secondary to intraoperative damages caused by 
mechanical or thermal trauma, gland devascularization, 
obstruction of venous outflow, and inadvertent parathyroid 
excision (14,15,17). Therefore, the question has been 
whether there are strategies or approaches a surgeon could 
follow intra-operatively to minimize PG injuries and 
hypoparathyroidism. One approach has been to see if there 
is a relationship between the number of PGs identified 
intra-operatively and post-operative hypoparathyroidism. 
To date, there are two schools of thought with some 
surgeons advocating routine identification of all PGs (i.e., 
the operating surgeon spending time in visualizing all or as 
many PGs as possible at surgery) while others advocating 
the opposite and would spend little to no time in visualizing 
PGs at surgery (i.e., selective identification).
Routine versus selective identification 
The term “routine identification” refers to a strategy where 
the surgeon would try his or her best to identify each and 
every PG in its orthotopic or non-orthotopic position (20-23). 
This has traditionally been the approach accepted by many 
surgeons. However, the pitfall with this strategy is that 
not all PGs could be found in their orthotopic or usual 
positions. For example, some superior PGs are located at 
the superior pole of the posterior thyroid gland near the 
cricothyroid junction and some inferior PGs may be located 
far away from the neck in the thymus and mediastinum 
(24,25). Therefore, even with the best intention, it may 
not be always possible to identify each and every PG at 
the time of total thyroidectomy. The other pitfall is that 
this strategy may lead to inadvertent damage to the nearby 
blood supply and therefore, may devitalize PGs leading 
hypoparathyroidism. Also, this strategy may unnecessarily 
prolong the operation. 
On the other hand, some surgeons advocate a selective 
approach where the PGs are encountered rather than 
being actively searched for during surgery. This approach 
might be more time-saving as the surgeon does not need to 
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search all sites and because of the less extensive dissection, 
the chance of inadvertently jeopardizing the blood supply 
to PGs would be less. Nevertheless, in either approaches, 
when parathyroid blood supply is jeopardized, expeditious 
autografting of the affected PG should be performed, 
although the benefit of autografting has also been 
questioned (26,27).
Supporting evidence for either approach
Given that the issue of whether to routinely identify or 
not identify PGs during total thyroidectomy has remained 
controversial, the present review aimed to look into 
the current literature for supporting evidence in either 
approach. To improve the clarity of the evidence, studies 
were divided into those reporting temporary (<6 months) 
and those reporting persistent/permanent (≥6 months) after 
operation. For studies reporting both, they were included in 
both tables.
The evidence for routine identification
Table 1 lists the studies which support the routine identification 
approach.
Temporary hypocalcemia
Bergenfelz et al. reported a multicenter retrospective 
audit with 3,660 patients, involving both benign and 
malignant thyroid diseases and various types of thyroid 
operations. Among these, 1,648 patients received bilateral 
thyroidectomy. It was found that at 6-week post-op, 10% 
and 8% of patients were on vitamin D and Ca supplements, 
Table 1 Publications supporting routine identification approach
Year
Author 
(reference)
No. of 
patients
Definition of hypoCa
Rate of 
hypoCa
Findings
1998 Pattou (28) 1,071 Temporary: serum calcium level under 
8.0 mg/dL (2 mmol/L) on at least two 
consecutive measurements
3.3% No. of PG identified in situ correlated with the 
outcome of hypoCa (P=0.01)
Permanent: requiring Ca or vitamin D 
therapy or both 1 year after surgery
1.1% No. of PGs identified in situ correlated with 
the outcome of hypoCa (P=0.01)
2002 Thomusch (10) 5,846 Temporary: calcium or vitamin D therapy 
required to treat clinical symptoms of 
tetany, regardless of calcium serum levels; 
within 6 months after operation
6.0–23.0% Identification of PG less than 2 was  
1.4 times more likely to develop temporary 
hypocalcemia (P=0.17)
Permanent: calcium or vitamin D therapy 
required to treat clinical symptoms of 
tetany, regardless of serum calcium levels; 
exceeded 6 months beyond operation
0.9–9.0% Identification of PG less than 2 was 4.1 times 
more likely to develop permanent hypoCa 
(P=0.001)
2008 Bergenfelz (21) 1,648 
(bilateral)
HypoCa treated with vitamin D at first 
follow-up after 1–6 weeks
2.6% No. of identified PG is protective to hypoCa 
(OR, 0.741; CI: 0.621–0.883)
2010 Sitges-Serra 
(23)
442 Temporary: iPTH <12 pg/mL at 1 month 
after surgery
18.1% Identified 1–2 PG had 52% hypoCa; identified 
3–4 PG had 30.5% hypoCa (P=0.018)
Permanent: serum calcium level under  
8.0 mg/dL (2 mmol/L) 1 year after 
operation
3.9% Identified 1–2 PG had 32% hypoCa; identified 
3 PG 3 had 22% hypoCa; identified 4 PG had 
5% hypoCa (P=0.096)
2014 Puzziello (29) 2,631 NA 27.9% Temporary hypoCa rate in PG identified is 
higher than PG not identified (29.2% vs. 
18.7%, P<0.01)
0.9% Permanent hypoCa rate in PG identified is 
lower than PG not identified
No., number; PG, parathyroid gland; hypoCa, hypocalcemia; PTH, parathyroid hormone; OR, odds ratio; CI, confidence interval; P, P 
value; NA, not applicable.
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respectively; and the number of identified PGs intra-
operatively was protective to hypocalcemia [odds ratio (OR), 
0.74; confidence interval (CI): 0.621–0.883]. Association 
with hypocalcemia at 6-month post-op was not analyzed 
since missing data was high (4.5%) (21).
Siteges-Serra et al. reported the outcome of post-
thyroidectomy hypocalcemia in 422 patients retrospectively, 
and found that 50.2% developed hypocalcemia post-
operatively, which was defined as Ca less than 2.0 mmol/L (23). 
At one month after operation the rate of hypoparathyroidism 
was 18.1%; and within the group of patients who had post-
operative hypocalcemia, identifying 3 or 4 PGs had less 
hypocalcemia than identifying 1 or 2 PGs (30.5% vs. 52.0%, 
P=0.018). However, one fifth of their patients underwent 
central neck dissection for thyroid cancer and the results 
were not adjusted for confounding factors. The rate of 
hypocalcemia at 1 year after operation was not associated 
with the number of PGs identified. 
Permanent hypocalcemia
A German retrospective multivariate analysis by Thomusch 
et al.  involving 5,846 patients underwent bilateral 
thyroidectomy showed that besides extent of thyroid 
operations and surgical technique, number of identified 
PGs less than 2 increased post-operative permanent 
hypocalcemia (OR, 4.1; P=0.001), which was defined as 
requiring Ca or vitamin D supplements 6 months after 
operation (10). Removal of a single PG was not associated 
with post-operative hypoparathyroidism. Similar trend was 
observed for transient hypocalcemia (less than 6 months) 
however statistical significance was not reached (OR, 1.7; 
P=0.700). Together with some other reports which showed 
that permanent hypoparathyroidism emerged exclusively 
after less than 3 PGs had been identified intra-operatively 
(22,30), it was suggested that at least 2 PGs should be 
identified and preserved in situ during operation (10).
This suggestion was also supported by Pattou et al. (28), 
who prospectively evaluated the incidence and predictive 
factors of hypocalcemia in 1,071 consecutive patients. It was 
found that number of PGs identified in situ during surgery 
was correlated with the outcome of hypocalcemia (P=0.010). 
Patients carried a high risk for permanent hypocalcemia (Ca 
<2 mmol/L and symptomatic 1 year after operation) if fewer 
than 3 PGs were identified in situ during surgery. When 
3 or more PGs identified and preserved during surgery, 
spontaneous recovery was observed in all patients except 
one (28).
Similar findings were reported in a recent multi-centre 
prospective study by Puzziello et al. involving 2,631 patients, 
showing that identifying PGs was important to prevent 
permanent hypocalcemia. Interestingly, the percentage 
of developing transient hypocalcemia in patients with 
identification of PGs intra-operatively was higher than 
in patients with PGs not identified (29.2% vs. 18.7%, 
P<0.010). This suggested that identifying PGs during 
operation may have a protective role in hypocalcemia 
in long-term, though in expense of a higher risk of 
hypocalcemia in short term (29). 
The evidence for selective identification
In contrast, some recent studies showed that patients with 
a greater number of PGs identified intra-operatively might 
be at greater risk of hypoparathyroidism. Some suggest that 
identification of PGs is not equivalent to preserving them; 
instead, may increase direct trauma or disrupt blood supply 
during surgical manipulation (29,31). Therefore, surgeons 
start to advocate “selective approach” while PGs are only 
sought in their orthotopic locations with no attempt to 
identify them elsewhere. It was hypothesized that with 
the adoption of extra-capsular dissection, not seeing a PG 
usually implies that it is being covered by vascularized tissue 
and therefore had a better chance of being in situ (31). 
Of course, this assumption is only valid in high quality 
extra-capsular dissection and experienced hands. Table 2 
summarizes the evidence in support of selective identification 
approach.
Temporary hypocalcemia
In 2000, a small Swedish prospective cohort by Lindblom 
et al. with 38 patients undergone total or near total 
thyroidectomy reported that number PGs identified 
intra-operatively was associated with Ca reduction within 
24 hours after operation via stepwise multiple linear 
regression (B=2.57, P=0.036) (32). Recently, Lang et al. 
reported a prospective study with 117 patients evaluating 
predictive factors of hypocalcemia after thyroidectomy and 
found that the more PGs identified intra-operatively, the 
more post-operative transient hypocalcemia (P=0.017) (34). 
Later the same group conducted another prospective study 
with 569 patients to specifically look into the relationship 
between number of PGs identified intra-operatively with 
post-operative hypocalcemia, and confirmed that greater 
number of PGs identified was an independent risk factor for 
temporary (within 24 hours) and protracted (4–6 weeks after 
operation) hypocalcemia (P<0.001, P=0.007, respectively). 
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Recovery time from protracted hypocalcemia for identifying 
<4 PGs was significantly shorter than identifying all 4 PGs 
(2.8 vs. 7 months, P<0.001). Chance of having 4 glands 
in situ decreased with greater number of PGs identified 
and identifying all 4 PGs has 1.8 times risk of temporary 
hypocalcemia (31). 
Similar results were found when comparing patients 
with 0–2 to 3–4 PGs seen intra-operatively. In a prospective 
study by Sheahan et al. with 126 patients underwent total 
thyroidectomy, 0–2 PGs identified has lower incidence 
of clinical hypocalcemia than 3–4 PGs found (3.2% vs. 
17.1%, P=0.02). No difference was observed in inadvertent 
parathyroidectomy between the two groups, which might 
suggest routine identification of PGs may not be helpful 
Table 2 Publications supporting selective identification approach
Year
Author 
(reference)
No. of 
patients
Definition of hypoCa
Rate of 
hypoCa
Findings
2000 Lindblom (32) 38 Two or more episodes of serum calcium 
less than 2.00 nmol/L or symptomatic within 
24 hours after surgery
26.3% Stepwise multiple linear regression analysis 
showed PGs identified was associated with 
Ca reduction (B=2.57, P=0.036)
2009 Pfleiderer (33) 162 Temporary: symptomatic patients 
with serum calcium <2.12 mmol/L or 
asymptomatic patients with serum calcium 
<2.0 mmol/L within 6 months post-op
42.6% When no PG identified, 70% have 
normocalcemia and 30% have temporary 
hypoCa; when all PG identified, 90% has 
temporary hypoCa
Permanent: symptomatic patients 
with serum calcium <2.12 mmol/L or 
asymptomatic patients with serum calcium 
<2.0 mmol/L 6 months beyond operation
5.6% When no PG identified, 70% have 
normocalcemia and 0% has permanent 
hypoCa; when all PG identified, 10% had 
permanent hypoCa
2012 Lang (34) 117 Serum Ca <1.9 mmol/L or symptomatic; 
requiring calcium +/− vitamin D supplements 
upon discharge after operation
14.5% More PG identified was associated with 
hypoCa (P=0.017)
2013 Sheahan (35) 126 Biochemical criteria: any post-operative 
serum calcium <2.00 mmol/L; clinical 
criteria: symptomatic hypoCa
22.2% 
(biochemical) 
and 10.3% 
(clinical)
Identified 0–2 PGs had lower incidence of 
clinical hypoCa than identified 3–4 PG (3.2% 
vs. 17.1%, P=0.02); difference in biochemical 
hypoCa was not significant (16.1% vs. 
28.1%, P=0.13)
2015 Prazenica (36) 788 NA NA Identified 0–2 PG had lower incidence of 
temporary hypoCa than identified 3–4 PG in 
univariate analysis (P=0.015)
NA NA Identified 0–2 PG had lower incidence of 
permanent hypoCa than identified 3–4 PG in 
univariate analysis (P=0.040)
2016 Lang (31) 569 Temporary: serum adjusted Ca <2.00 mol/L  
or need for oral calcium or vitamin D 
supplements to maintain normocalcemia 
at 24 h after operation; protracted: a 
subnormal PTH <1.2 pmol/L or need for 
oral calcium or vitamin D supplements to 
maintain normocalcemia at post-operative 
4–6 weeks
Temporary = 
22.8%; 
protracted = 
12.1%
Greater No. of PG identified was an 
independent risk factor for temporary and 
protracted hypoCa (P<0.001, P=0.007); 
recovery time from protracted hypoCa 
for identifying <4 PGs was shorted than 
identifying all 4 PG (2.8 vs. 7 months, 
P<0.001); identifying all 4 PG has 1.8× of 
temporary hypoCa
Permanent: need calcium or vitamin D 
supplements for more than 1 year after 
operation
2.6% Identified 4 PGs had higher permanent 
hypoCa rate than identified 0–1 PGs (11.2% 
vs. 1.5%, P<0.001); but not an independent 
risk factor (P=0.702) in multivariate analysis
No., number; PG, parathyroid gland; hypoCa, hypocalcemia; PTH, parathyroid hormone; OR, odds ratio; P, P value; NA, not applicable.
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in preventing inadvertent parathyroidectomy (35). In a 
retrospective study by Prazenica et al. with 788 patients, higher 
temporary hypocalcemia (P=0.015) was found in 3–4 PGs 
identified group (36). In the study of Puzziello et al. (29), 
although it suggested that number of identified PGs may 
increase permanent hypocalcemia, it was associated with 
more transient hypocalcemia.
Permanent hypocalcemia
Pflederer et al. reported a prospective cohort involving 162 
patients who underwent total or completion thyroidectomy (33). 
Association test between number of PGs identified and the 
development of hypocalcemia produced a significant result 
in post-operative 6 months (Chi =11.4, P=0.022). When 
no PGs were seen, 70% had normo-calcemia and 30% has 
temporary hypocalcemia. For those with all PGs identified, 
90% developed temporary hypocalcemia and 10% with 
permanent hypocalcemia, which required exogenous Ca and 
vitamin D beyond 6 months after operation (33).
Similarly, a recently published prospective study by Lang 
et al. with 569 patients who underwent total thyroidectomy 
for benign disease reported that permanent hypocalcemia, 
which was defined as requiring exogenous Ca or vitamin 
D one year after operation, was significantly higher 
in patient with 4 PGs identified than in patients with 
0–1 PGs identified (11.2% vs. 1.5%, P<0.001). Although 
the number of PGs identified was not an independent risk 
factor (P=0.702) in multivariate analysis, this might be due 
to small number of permanent hypocalcemia in the study 
(n=15, 2.6%) (31). Similarly, Prazenica et al. also found that 
identifying 4 PGs intra-operatively had higher permanent 
hypocalcemia rate than identifying 0–1 PGs in univariate 
analysis (P=0.040) (36).
Shortcomings with the literature
It is worth noting that majority of the studies were 
retrospective in design, for instance, multi-institutional 
observational studies and audits, thus only the association but 
not the causative relationship can be determined. Moreover, 
the low incidence of permanent hypoparathyroidism, which 
was reported to be 0–3.6% (1), leads to lack of statistical 
significance in the association test between number of 
identified PGs and permanent hypocalcemia. Although 
multi-institutional studies provide large sample size, 
they involved a heterogeneous population with different 
inclusion and exclusion criteria, various extents of thyroid 
resections (total or subtotal thyroidectomy, bilateral 
lobectomy, completion thyroidectomy, central neck 
dissection, etc.), different definition of hypoparathyroidism, 
drug prescription and follow-up protocol. These may 
miss out certain confounding factors that give rise to 
postsurgical hypoparathyroidism (1,17). On the other hand, 
single-institutional studies provide clearer definition and 
better quality data. However, they were frequently under 
power due to small sample size and the results may not be 
applicable in other institutions due to different volume of 
operations and surgeon’s experience. 
A systemic review and meta-analysis focusing on 
reducing post-thyroidectomy hypocalcemia found that 
no measures, including intra-operative PG identification, 
were significantly associated with reduction of hypocalcemia, 
given the majority of trials were of low quality due 
to a lack of blinding and also wide variability in study 
design and definitions (37). So far there is no meta-
analysis specifically summarizes the relationship of intra-
operative identifications of PGs with post-operative 
hypoparathyroidism; understandingly it  would be 
difficult because of the very heterogeneous studies. 
Moreover, an inevitable limitation for all studies is that 
PGs were “identified” in situ solely based on operative 
surgeon’s assessment without any histological proof; 
understandingly biopsy of the identified PG may actually 
inflict more damage and thus lead to more iatrogenic 
hypoparathyroidism. In addition, the current available 
studies only focus on the relationship between number 
of identified PGs and hypocalcemia, which may not truly 
reflect on the comparison between routine and selective 
identification approach. A lot of time PGs were encountered 
during dissection without surgeon’s intention to look 
for them. Thus, a high number of PGs identified is not 
necessarily equivalent to adopting a routine identification 
approach. It is also difficult to have carried out prospective 
study or randomized controlled trial to compare these 
two approaches, since a large number of patients would be 
required to ensure adequate power. 
Relationship between number of identified PGs 
and parathyroid function 
Despite the conflicting data in the literature, one 
thing is clear: to reduce the risk of postoperative 
hypoparathyroidism, the ability of leaving as many 
“vascularized” PGs  in situ is very important. In a 
prospective study of 657 patients who underwent first-
time total thyroidectomy, the prevalence of hypocalcemia 
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and of protracted and permanent hypoparathyroidism were 
inversely related to the PGs remaining in situ score (i.e., 
4 minus “auto-transplanted PGs” minus “PGs in 
specimen”). By logistic regression, this score turned out to 
be one of the most significant variables influencing acute 
and chronic parathyroid failures. On the other hand, the 
number of PGs identified intraoperatively did not appear 
to have any impact on transient, protracted or permanent 
hypocalcemia (38). 
Similarly, in a retrospective review of 454 patients who 
underwent total thyroidectomy for papillary thyroid carcinoma, 
the number of PGs preserved was obtained by subtracting the 
number of PGs in a given specimen from 4. It was found that 
the incidence of transient hypoparathyroidism increased when 
there were three or fewer preserved PGs than when all four 
PGs were preserved (P=0.004), but did not affect permanent 
hypoparathyroidism. During total thyroidectomy, preserving 
at least one PG with an intact blood supply appeared to 
be sufficient to prevent permanent hypoparathyroidism 
when auto-transplant was not performed (39). Lang et al. 
also showed that the number of PG in situ was inversely 
proportional to post-thyroidectomy temporary, protracted 
and permanent hypoparathyroidism (31). In a study about 
multi-factorial scoring system to predict post thyroidectomy 
hypocalcemia so as to enable safe discharge within 24 hours 
of surgery with 145 patients, lesser number of PG preserved 
at surgery was one of the significant predictive factors 
(P=0.001) (40).
Identifying PG is not a safeguard for protecting its 
function, because how we adequately assess the viability 
of the PG after finding it out based on macroscopic 
appearance is questionable due to subjective assessment and 
inter-observant variation. Moreover, function of discolored 
glands was not necessarily impaired and may recover 
within a short time after surgery (41). On the other hand, 
absence of discoloration was not a reliable way to suggest 
intact PG blood supply (42). Selective auto-transplantation 
was advocated for de-vascularized or inadvertent removed 
PGs. However, for PGs that were identified in situ, an 
intact vascular pedicle seemed cannot guarantee adequate 
function of PGs, because protracted and permanent 
hypoparathyroidism were also seen in patients with PGs 
that seemingly had adequate blood supply (43). Occasionally 
a PG can look normal even though its vascular pedicle 
seemed to be unsafe, and some surgeons evaluated blood 
supply for controversial PG by making a small incision in 
it with a cold knife (44). Yet it was also found that surgeons 
differ substantially in the ability of predicting risk of 
hypoparathyroidism during thyroid surgery (45). Thus, an 
objective and less invasive assessment is warranted. 
Assessing viability of in situ PGs
So now the question continued on how we could assess 
parathyroid viability in real-time, and whether it is possible 
to identify and preserve PGs in situ without trying to dissect 
and expose them out, limiting the risk of vascular injury. 
Studies have been going on for locating and predicting 
function of PGs with indocyanine green (ICG) fluorescent 
imaging in both thyroid and parathyroid surgery (46-52). 
ICG is a water-soluble molecule that binds to plasma 
protein and confined to intravascular compartment. It will 
emit fluorescent light when being excited by near-infrared 
light (NIR); thus, the combination of ICG and NIR may 
provide real-time assessment on tissue perfusion within 
a focused area reflected by the fluorescent light intensity. 
ICG fluorescent imaging potentially helps locate PGs and 
thus prevent inadvertent parathyroidectomy or damaging 
them (48). Moreover, ICG angiography may provide 
quantitative evaluation of in situ PG perfusion after total 
thyroidectomy, and could be a good predictor for post-
operative hypoparathyroidism (46,47,50,51). Although 
currently these reported studies were mainly concerning 
feasibility with a relative small sample size, ICG fluorescent 
angiography could potentially be a less invasive option for 
identifying PGs during thyroidectomy and provide more 
accurate prediction of parathyroid function. 
Conclusions
It remains controversial on how the number of PGs 
identified during total thyroidectomy may affect iatrogenic 
hypoparathyroidism. More PGs identif ied during 
surgery appear to be associated with a greater risk of 
temporary hypoparathyroidism. Regarding to permanent 
hypoparathyroidism, conclusion remains unclear because of 
the low incidence and heterogeneity of studies. Moreover, 
one should realize that studying the association between 
numbers of PGs identified intra-operatively and post-
thyroidectomy hypoparathyroidism did not directly address 
on the issue of whether or not the surgeon should actively 
seek all PGs regardless of their location. To better answer 
this question, to identify or not identify the PGs during 
total thyroidectomy, a prospective comparative study or 
even a randomized control trial might be required, although 
this would be difficult due to requirement of large sample 
S27Gland Surgery, Vol 6, Suppl 1 December 2017
© Gland Surgery. All rights reserved. Gland Surg 2017;6(Suppl 1):S20-S29gs.amegroups.com
size. In order to prevent iatrogenic hypocalcemia, the 
traditional teaching of leaving at least one vascularized 
pedicle attached to an in situ PG still remains true. With 
the new advancement in ICG fluorescent angiographic 
technology, whether to identify or not identify PGs also 
depends on the method to localize and assess its function in 
a non-invasive manner.
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